GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Newbury Pharmaceuticals NEWBRY.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.70

+5.59%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2026

Revenue

SEK 42.7m

FY2021FY2026

Net income

−SEK 22.9m

FY2021FY2026

Free cash flow

−SEK 19.7m

FY2021FY2026

Shareholders' equity

SEK 19.6m

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
RevenueSEK 42.7m—SEK 36.8mSEK 10.3mSEK 5.5mSEK 2.8m
Operating income−SEK 20.7m−SEK 20.6m−SEK 14.1m−SEK 19.6m−SEK 14.7m−SEK 5.6m
Net income−SEK 22.9m−SEK 20.6m−SEK 15.4m−SEK 19.4m−SEK 14.7m−SEK 5.6m
Diluted earnings per share-0.75-0.67-0.64-1.00-0.75-0.35

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assetsSEK 76.2m—SEK 90.9mSEK 72.9mSEK 86.9mSEK 42.8m
Cash and short-term investments——SEK 15.3mSEK 8.5mSEK 33.3mSEK 13.1m
Total liabilitiesSEK 56.6m—SEK 39.0mSEK 23.5mSEK 18.1mSEK 4.3m
Shareholders' equitySEK 19.6m—SEK 51.9mSEK 49.4mSEK 68.8mSEK 38.5m
Shares outstanding30m31m24m20m20m16m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations−SEK 19.7m—−SEK 23.7m−SEK 23.2m−SEK 15.0m−SEK 4.1m
Capital spending—−SEK 2.2m−SEK 2.9m−SEK 862,000−SEK 24.4m−SEK 23.1m
Free cash flow−SEK 19.7m—−SEK 26.6m−SEK 24.1m−SEK 39.4m−SEK 27.2m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
RevenueSEK 13.6mSEK 8.9mSEK 8.5mSEK 11.7m−SEK 25.7mSEK 6.7mSEK 12.4mSEK 6.5m
Operating income−SEK 6.0m−SEK 4.4m−SEK 4.1m−SEK 6.1m−SEK 8.8m−SEK 6.2m−SEK 1.4m−SEK 4.2m
Net income−SEK 6.8m−SEK 5.0m−SEK 4.6m−SEK 6.5m−SEK 7.5m−SEK 6.6m−SEK 1.9m−SEK 4.6m
Diluted earnings per share-0.22-0.16-0.15-0.21-0.25-0.21-0.06-0.19
Cash from operations−SEK 5.0m−SEK 10.0mSEK 2.0m−SEK 6.0m—−SEK 5.0m−SEK 6.0mSEK 4.0m
Total assetsSEK 76.2mSEK 84.5mSEK 77.3mSEK 76.6m—SEK 92.9mSEK 87.7mSEK 88.5m
Cash and short-term investments——————SEK 12.9mSEK 19.4m
Shareholders' equitySEK 19.6mSEK 26.3mSEK 31.3mSEK 35.8m—SEK 53.5mSEK 44.8mSEK 46.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue60.8%72.1%—
Operating income1.8%29.7%—
Net income5.7%32.8%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings-2.1-1.7-5.5-3.1-9.3
Price to sales1.1—2.35.824.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.